Search Results

channeling blood during Haemodialysis Treatement.

Not Found

The provided documents are a 510(k) clearance letter and an "Indications for Use" statement for a medical device. This type of regulatory submission does not contain the detailed study information, acceptance criteria, or performance data that would be found in a clinical study report or a more comprehensive premarket application (like a PMA).

Therefore, based only on the provided text, I cannot answer most of your specific questions. I can only infer very limited information.

Here's a breakdown of what can and cannot be answered from the provided text:

Information that CANNOT be extracted from the provided text:

• 1. A table of acceptance criteria and the reported device performance: This information is not present. A 510(k) clearance letter confirms substantial equivalence, but doesn't detail performance metrics or acceptance criteria unless specifically included in the "Indications for Use" which it isn't here.
• 2. Sample sized used for the test set and the data provenance: Not available.
• 3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable/available for this type of document.
• 4. Adjudication method: Not applicable/available.
• 5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This device is an "Extracorporeal Blood Circuit," not an AI-powered diagnostic device involving human readers.
• 6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable. This is not an algorithm/AI device.
• 7. The type of ground truth used: Not applicable/available.
• 8. The sample size for the training set: Not applicable/available (not an AI device).
• 9. How the ground truth for the training set was established: Not applicable/available (not an AI device).

What can be extracted/inferred:

• Device Name: Extracorporeal Blood Circuit
• Intended Use: "channeling blood during Haemodialysis Treatement."
• Regulatory Class: II
• Product Code: 78 FJK
• Submission Type: 510(k) Premarket Notification
• Manufacturer: Haidylena Medical
• Date Cleared: Apr 30, 1999
• Substantial Equivalence: The device was found substantially equivalent to predicate devices. This implies that its performance (safety and efficacy) is considered on par with existing, legally marketed devices for the same intended use, but the specific performance data is not detailed in these documents.

Conclusion:

The provided documents are regulatory clearance letters and an "indications for use" statement. They do not contain the specific performance study details (acceptance criteria, sample sizes, ground truth methods, expert qualifications, etc.) that would typically be required to answer your questions. These details would be found in the full 510(k) submission summary or associated testing reports, which are not included here.

Ask a specific question about this device